Lewis Lyons, MD
Vascular Surgery · Mobile, ALNPI 1700052966
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,710 of the $5,640 with a category attached, or 83.5%. 18 manufacturers reported payments, led by Endologix LLC at 26.6% of the total. Reporting peaked in 2019 at $3,953 and has fallen 93.2% since, to $269 in 2025. That places this record below the midpoint for vascular surgery clinicians in AL, where the typical reported total is $5,256.
Across 88 payments — averaging $64.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Endologix LLC$2K
- Silk Road Medical, Inc.$1K
- Cook Medical LLC$885
- W. L. Gore & Associates, Inc.$773
- Boston Scientific$436
- Abbott$204
- plus $703 from 12 others
Across 3 payments — averaging $750.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- W. L. Gore & Associates, Inc.$2K
What the payments were for
- Travel & lodging$91716%
- Food & beverage$4,71084%
- Education$130%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Endologix LLC | 13 | $1,502 |
| Silk Road Medical, Inc. | 6 | $1,137 |
| Cook Medical LLC | 19 | $885 |
| W. L. Gore & Associates, Inc. | 15 | $773 |
| Boston Scientific | 8 | $436 |
| Abbott | 3 | $204 |
| Getinge USA Sales, LLC | 3 | $173 |
| Baxter Healthcare | 3 | $124 |
| Johnson & Johnson | 6 | $98 |
| EKOS Corporation | 3 | $93 |
| Tactile Systems Technology Inc | 1 | $75 |
| Bard Peripheral Vascular, Inc. | 2 | $39 |
| Bolton Medical Inc | 1 | $24 |
| Teleflex LLC | 1 | $18 |
| Venclose Inc. | 1 | $18 |
| Acera Surgical, Inc. | 1 | $18 |
| Solventum Corporation | 1 | $15 |
| Kerecis Limited | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENROUTE Transcarotid Neuroprotection System$1,055
- ENROUTE Transcarotid Stent System$1,055
- ENHANCE Transcarotid Peripheral Access Kit$1,055
- ENROUTE 0.014 Guidewire$1,055
- AFX$637
- EXCLUDER Conformable AAA Endoprosthesis with Active Control$257
- Alto Abdominal Stent Graft System$225
- Ovation$172
- Torus Stent Graft System$140
- ENDOCROSS Device$140
- Perclose ProGlide suture mediated closure system$110
- Cook Medical AFEN$108
How this compares
$5,640 in reported general payments places this provider in the 50th percentile of 61 vascular surgery providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 53 | $41,129 |
| XareltoRivaroxaban | 19 | $17,496 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 97 | $563 |
| ClopidogrelClopidogrel Bisulfate | 75 | $524 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 27 | $341 |
| Gabapentin | 28 | $338 |
| Atorvastatin Calcium | 13 | $121 |
| Clindamycin Hcl | 12 | $118 |
| Carvedilol | 21 | $22 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $98 | $17,49619 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 61 vascular surgery providers in Alabama.
Other vascular surgery in Mobile
- Mina JacobMobile$19K
- Benjamin MakamsonMobile$18K
- Lee FergusonMobile$13K
- Cullen McCarthyMobile$8K
- Glenn EssesMobile$7K
- Michael DoMobile$7K
- William HardyMobile$3K
- Melanie RoseMobile$3K
- Ralph PfeifferMobile$2K
- Albert PacificoBirmingham$5.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.